Skip to main content

Neuropathic pain’s biopsychosocial effects

Neurological Sciences volume 38, pages 1993–1997 (2017)Cite this article

Abstract

The aim of our study is to understand neuropathic pain’s social, psychological, and biological effects on the patients. All of the patients who were diagnosed with neuropathic pain (NP) by a neurologist were invited to participate in the study. The diagnoses were made based on the patients’ history and symptoms and the results of their neurological examinations. Demographic characteristics (age and pain duration), diagnoses, and medical histories of the patients were recorded. Average daily pain intensity was measured using a 100-mm visual analogue scale (VAS). Quality of life was measured with RAND 36-Item Health Survey 1.0. Pittsburgh Sleep Quality Index (PSQI) was used to examine the quality of sleep, and Beck Depression Scale was used to examine depression status of the patients. A total of 26 patients (14 male, 12 female) between 33 and 79 years of age participated in the study. There were no dropouts from the study. Eleven (42.3%) patients’ mood was normal and the others (57.7%) had different levels of depression. Two patients’ (7.7%) quality of sleep was normal, but 24 (92.3%) of the patients’ quality of sleep was poor. The patients’ pain intensity was at an important and high value (VAS: 6.88). The most important result of this clinical study was that the biopsychosocial approach would be appropriate to understand and treat NP. The biopsychosocial approach to pain addresses psychological, sociocultural factors, and biomedical/physiological aspects. We wanted to draw attention to NP’s psychological, emotional and sociocultural characteristics to show that the NP treatment can be applied within this framework.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Graph 1

References

  1. https://www.iasp-pain.org/GlobalYear/NeuropathicPain. Accessed 18.06.2017

  2. https://www.practicalpainmanagement.com/pain/neuropathic/diabetic-neuropathy/assessment-treatment-neuropathic-pain. Accessed 25.07.2017

  3. Attal N, Bouhassira D (1999) Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand Suppl 173:12–24

    CAS  Article  PubMed  Google Scholar 

  4. Merskey H, Bogduk N (1994) Classification of chronic pain, 2nd edn. IASP Press, Seattle

    Google Scholar 

  5. Fear C (2010) Neuropathic pain: clinical features, assessment and treatment. Nurs Stand 25(6):35–40

    Article  PubMed  Google Scholar 

  6. O’Connor AB (2009) Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. PharmacoEconomics 27:95–112

    Article  PubMed  Google Scholar 

  7. Nicholson B, Verma S (2004) Comorbidities in chronic neuropathic pain. Pain Med 5:9–27

    Article  Google Scholar 

  8. http://www.paineurope.com/articles/the-biopsychosocial-model-and-chronic-pain-an-overview. Accessed 18.06.2017

  9. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, Treede RD (2011) A new definition of neuropathic pain. Pain 152:2204–2205

    Article  PubMed  Google Scholar 

  10. Engel G (1977) The need for a new medical model: a challenge for biomedicine. Science 196:129–136

    CAS  Article  PubMed  Google Scholar 

  11. Argoff CE (2007) The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 23(1):15–22

    Article  PubMed  Google Scholar 

  12. Beniczky S, Tajti J, Timea VE et al (2005) Evidence-based pharmacological treatment of neuropathic pain syndromes. J Neural Transm 112:735–749

    CAS  Article  PubMed  Google Scholar 

  13. https://www.neuropathyjournal.org/coping-with-neuropathy-1-0-pain-anxiety-and-depression/. Accessed 02.08.2017

  14. McCarberg BH, Billington R (2006) Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care 12(9 Suppl):S263–S268

    PubMed  Google Scholar 

  15. Harden N, Cohen M (2003) Neuropathic pain: from mechanisms to treatment strategies. Unmet needs in the management of neuropathic pain. J Pain Symptom Manag 25(5):S12–S17

    Article  Google Scholar 

  16. Hayes MHS, Patterson DG (1921) Experimental development of the graphic rating method. Psychol Bull 18:98–99

    Google Scholar 

  17. Ware JE Jr, Sherbourne CD (1992) The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  18. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213

    CAS  Article  PubMed  Google Scholar 

  19. Agargun MY, Kara H, Anlar O (1996) Pittsburgh uyku kalitesi indeksinin geçerliği ve güvenirliği. Turk Psikiyatri Derg 7:07–15

    Google Scholar 

  20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    CAS  Article  PubMed  Google Scholar 

  21. Benbow SJ, Wallymahmed ME, Macfarlane IA (1998) Diabetic peripheral neuropathy and quality of life. Q J Med 91:733–737. doi:10.1093/qjmed/91.11.733

    CAS  Article  Google Scholar 

  22. Melikoglu MA, Celik A (2017) Does neuropathic pain affect the quality of sleep? Eurasian J Med 49:40–43

    Article  PubMed  PubMed Central  Google Scholar 

  23. Martin A, Heapy A, Moore B, Masheb R, Driscoll M, Kerns RA (2014) Mediation model of neuropathic pain and sleep quality: the role of depressed affect and pain interference. J Pain 15(4):S104

  24. Thomson CH, Cassell O, Peach H, Holloway S, Garioch J, Moncrieff M (2017) Neuropathic pain and quality of life after wide local excision and sentinel lymph node biopsy for melanoma: a multicentre study. Melanoma Res 27(2):121–125

    Article  PubMed  Google Scholar 

  25. Meyer-Rosberg K, Burckhardt CS, Huizar K et al (2001) A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain 5:391–403

    CAS  Article  PubMed  Google Scholar 

  26. Rowbotham DJ (2002) Neuropathic pain and quality of life. Eur J Pain 6(Issue SB):19–24

    Article  PubMed  Google Scholar 

  27. Colloca L et al (2017) Neuropathic pain. Nat Rev Dis Primers 3:17002

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS (1997) Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13(2):116–137

    CAS  Article  PubMed  Google Scholar 

  29. http://www.paineurope.com/articles/the-biopsychosocial-model-and-chronic-pain-an-overview. Access 15.06.2017

Download references

Author information

Affiliations

  1. School of Physical Therapy and Rehabilitation, Mustafa Kemal University, Antakya, Hatay, Turkey

    Esra Dogru Huzmeli

  2. Neurology Department, Tayfur Ata Sokmen Medicine Faculty, Mustafa Kemal University, Antakya, Hatay, Turkey

    Ismet Melek

Authors
  1. Esra Dogru Huzmeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ismet Melek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esra Dogru Huzmeli.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dogru Huzmeli, E., Melek, I. Neuropathic pain’s biopsychosocial effects. Neurol Sci 38, 1993–1997 (2017). https://doi.org/10.1007/s10072-017-3092-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-017-3092-5

Keywords

  • Neuropathic pain
  • Biopsychosocial
  • Quality of life
  • Quality of sleep
  • Depression